DNER and cardiac arrhythmia: Another approach could be the administration of small molecules that modulate epigenetic factors, such as inhibitors of histone deacetylases and BET/bromodomain proteins, which are well tolerated in vivo and have been shown to ameliorate various cardiac pathologies (e.g., hypertrophy and fibrosis) (17) but have never been tested in arrhythmias.